Next report date
Report period
Q1 2024
EPS estimate
0.12USD
Revenue estimate
67.01 MUSD
−50.98 MUSD
90.47 MUSD
74.69 M
Om NXERA PHARMA CO LTD
Sektor
Bransch
VD
Chris Cargill
Webbplats
Huvudkvarter
Tokyo
Employees (FY)
350
Grundat
2002
ISIN
JP3431300007
FIGI
BBG000C0N8Z4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
